Jason R. McCarthy, Ph.D. - Publications

Affiliations: 
University of Connecticut, Storrs, CT, United States 
Area:
Porphyrins, porphyrinoids, chemosensing

14/151 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Greco JA, Shima S, Wagner NL, McCarthy JR, Atticks K, Brückner C, Birge RR. Two-photon spectroscopy of the Q-bands of meso -tetraphenyl-porphyrin and -chlorin framework derivatives Journal of Physical Chemistry C. 119: 3711-3724. DOI: 10.1021/Jp5117883  0.51
2012 Brückner C, Ogikubo J, McCarthy JR, Akhigbe J, Hyland MA, Daddario P, Worlinsky JL, Zeller M, Engle JT, Ziegler CJ, Ranaghan MJ, Sandberg MN, Birge RR. meso-arylporpholactones and their reduction products. The Journal of Organic Chemistry. 77: 6480-94. PMID 22734444 DOI: 10.1021/Jo300963M  0.67
2011 Brückner C, Götz DC, Fox SP, Ryppa C, McCarthy JR, Bruhn T, Akhigbe J, Banerjee S, Daddario P, Daniell HW, Zeller M, Boyle RW, Bringmann G. Helimeric porphyrinoids: stereostructure and chiral resolution of meso-tetraarylmorpholinochlorins. Journal of the American Chemical Society. 133: 8740-52. PMID 21534626 DOI: 10.1021/Ja202451T  0.71
2009 Panizzi P, Nahrendorf M, Wildgruber M, Waterman P, Figueiredo JL, Aikawa E, McCarthy J, Weissleder R, Hilderbrand SA. Oxazine conjugated nanoparticle detects in vivo hypochlorous acid and peroxynitrite generation Journal of the American Chemical Society. 131: 15739-15744. PMID 19817443 DOI: 10.1021/Ja903922U  0.303
2009 McCarthy JR, Bhaumik J, Merbouh N, Weissleder R. High-yielding syntheses of hydrophilic conjugatable chlorins and bacteriochlorins. Organic & Biomolecular Chemistry. 7: 3430-6. PMID 19675897 DOI: 10.1039/B908713C  0.344
2009 Bhaumik J, Weissleder R, McCarthy JR. Synthesis and photophysical properties of sulfonamidophenyl porphyrins as models for activatable photosensitizers. The Journal of Organic Chemistry. 74: 5894-901. PMID 19610602 DOI: 10.1021/Jo900832Y  0.337
2007 McCarthy JR, Weissleder R. Model systems for fluorescence and singlet oxygen quenching by metalloporphyrins. Chemmedchem. 2: 360-5. PMID 17245681 DOI: 10.1002/Cmdc.200600244  0.337
2005 McCarthy JR, Perez JM, Brückner C, Weissleder R. Polymeric nanoparticle preparation that eradicates tumors. Nano Letters. 5: 2552-6. PMID 16351214 DOI: 10.1021/Nl0519229  0.467
2005 Zeller M, Hunter AD, McCarthy JR, Capetta SH, Brückner C. Crystal and molecular structure of [5,10,15,20-tetrakisphenyl-2-ethoxy-3- oxa-chlorinato]Ag(II) Journal of Chemical Crystallography. 35: 935-942. DOI: 10.1007/S10870-005-5176-Y  0.501
2004 McCarthy JR, Hyland MA, Brückner C. Synthesis of indaphyrins: meso-tetraarylsecochlorin-based porphyrinoids containing direct o-phenyl-to-beta-linkages. Organic & Biomolecular Chemistry. 2: 1484-91. PMID 15136804 DOI: 10.1039/B401629G  0.718
2003 McCarthy JR, Jenkins HA, Brückner C. Free base meso-tetraaryl-morpholinochlorins and porpholactone from meso-tetraaryl-2,3-dihydroxy-chlorin. Organic Letters. 5: 19-22. PMID 12509880 DOI: 10.1021/Ol027072A  0.537
2003 McCarthy JR, Hyland MA, Brückner C. Indaphyrin, a meso-tetraphenylsecochlorin-derived chromophore incorporating o-phenyl-to-β-linkages Chemical Communications. 9: 1738-1739. DOI: 10.1039/B304647H  0.703
2003 Brückner C, McCarthy JR, Daniell HW, Pendon ZD, Ilagan RP, Francis TM, Ren L, Birge RR, Frank HA. A spectroscopic and computational study of the singlet and triplet excited states of synthetic β-functionalized chlorins Chemical Physics. 294: 285-303. DOI: 10.1016/S0301-0104(03)00282-9  0.519
2003 McCarthy JR, Melfi PJ, Capetta SH, Brückner C. Use of Ag(II) as a removable template in porphyrin chemistry: Diol cleavage products of [meso-tetraphenyl-2,3-cis-diolchlorinato]silver(II) Tetrahedron. 59: 9137-9146. DOI: 10.1016/J.Tet.2003.09.067  0.523
Low-probability matches (unlikely to be authored by this person)
2009 McCarthy JR, Patel P, Botnaru I, Haghayeghi P, Weissleder R, Jaffer FA. Multimodal nanoagents for the detection of intravascular thrombi. Bioconjugate Chemistry. 20: 1251-5. PMID 19456115 DOI: 10.1021/Bc9001163  0.291
2015 Stein-Merlob AF, Kessinger CW, Erdem SS, Zelada H, Hilderbrand SA, Lin CP, Tearney GJ, Jaff MR, Reed GL, Henke PK, McCarthy JR, Jaffer FA. Blood Accessibility to Fibrin in Venous Thrombosis is Thrombus Age-Dependent and Predicts Fibrinolytic Efficacy: An In Vivo Fibrin Molecular Imaging Study. Theranostics. 5: 1317-27. PMID 26516370 DOI: 10.7150/Thno.12494  0.281
2012 Hara T, Bhayana B, Thompson B, Kessinger CW, Khatri A, McCarthy JR, Weissleder R, Lin CP, Tearney GJ, Jaffer FA. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence. Jacc. Cardiovascular Imaging. 5: 607-15. PMID 22698530 DOI: 10.1016/J.Jcmg.2012.01.017  0.278
2010 McCarthy JR, Korngold E, Weissleder R, Jaffer FA. A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis. Small (Weinheim An Der Bergstrasse, Germany). 6: 2041-9. PMID 20721949 DOI: 10.1002/Smll.201000596  0.277
2012 Nahrendorf M, McCarthy JR, Libby P. Over a hump for imaging atherosclerosis: nanobodies visualize vascular cell adhesion molecule-1 in inflamed plaque. Circulation Research. 110: 902-3. PMID 22461358 DOI: 10.1161/Circresaha.112.267260  0.276
2012 Ripplinger CM, Kessinger CW, Li C, Kim JW, McCarthy JR, Weissleder R, Henke PK, Lin CP, Jaffer FA. Inflammation modulates murine venous thrombosis resolution in vivo: assessment by multimodal fluorescence molecular imaging. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 2616-24. PMID 22995524 DOI: 10.1161/Atvbaha.112.251983  0.276
2012 Erdem SS, Sazonova IY, Hara T, Jaffer FA, McCarthy JR. Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles. Methods in Enzymology. 508: 191-209. PMID 22449927 DOI: 10.1016/B978-0-12-391860-4.00010-0  0.273
2007 McCarthy JR, Kelly KA, Sun EY, Weissleder R. Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine (London, England). 2: 153-67. PMID 17716118 DOI: 10.2217/17435889.2.2.153  0.27
2008 McCarthy JR, Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Advanced Drug Delivery Reviews. 60: 1241-51. PMID 18508157 DOI: 10.1016/J.Addr.2008.03.014  0.27
2017 Stein-Merlob AF, Hara T, McCarthy JR, Mauskapf A, Hamilton JA, Ntziachristos V, Libby P, Jaffer FA. Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging. Circulation. Cardiovascular Imaging. 10. PMID 28487316 DOI: 10.1161/Circimaging.116.005813  0.269
2015 Kessinger CW, Kim JW, Henke PK, Thompson B, McCarthy JR, Hara T, Sillesen M, Margey RJ, Libby P, Weissleder R, Lin CP, Jaffer FA. Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring. Plos One. 10: e0116621. PMID 25680183 DOI: 10.1371/Journal.Pone.0116621  0.264
2010 McCarthy JR. Nanomedicine and Cardiovascular Disease. Current Cardiovascular Imaging Reports. 3: 42-49. PMID 20369034 DOI: 10.1007/S12410-009-9002-3  0.261
2010 McCarthy JR, Bhaumik J, Karver MR, Sibel Erdem S, Weissleder R. Targeted nanoagents for the detection of cancers. Molecular Oncology. 4: 511-28. PMID 20851695 DOI: 10.1016/J.Molonc.2010.08.003  0.26
2010 Chang K, Francis SA, Aikawa E, Figueiredo JL, Kohler RH, McCarthy JR, Weissleder R, Plutzky J, Jaffer FA. Pioglitazone suppresses inflammation in vivo in murine carotid atherosclerosis: novel detection by dual-target fluorescence molecular imaging. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1933-9. PMID 20689078 DOI: 10.1161/Atvbaha.110.206342  0.257
2011 Yoo H, Kim JW, Shishkov M, Namati E, Morse T, Shubochkin R, McCarthy JR, Ntziachristos V, Bouma BE, Jaffer FA, Tearney GJ. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nature Medicine. 17: 1680-4. PMID 22057345 DOI: 10.1038/Nm.2555  0.254
2015 Cui J, Kessinger CW, McCarthy JR, Sosnovik DE, Libby P, Thadhani RI, Jaffer FA. In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula. Arteriosclerosis, Thrombosis, and Vascular Biology. 35: 189-96. PMID 25395614 DOI: 10.1161/Atvbaha.114.304483  0.254
2011 McCarthy JR, Jaffer FA. The role of nanomedicine in the imaging and therapy of thrombosis. Nanomedicine (London, England). 6: 1291-3. PMID 22026372 DOI: 10.2217/Nnm.11.128  0.249
2016 Bozhko D, Osborn EA, Rosenthal A, Verjans JW, Hara T, Kellnberger S, Wissmeyer G, Ovsepian SV, McCarthy JR, Mauskapf A, Stein AF, Jaffer FA, Ntziachristos V. Quantitative intravascular biological fluorescence-ultrasound imaging of coronary and peripheral arteries in vivo. European Heart Journal Cardiovascular Imaging. PMID 28031233 DOI: 10.1093/Ehjci/Jew222  0.245
2012 Ghosh K, Kanapathipillai M, Korin N, McCarthy JR, Ingber DE. Polymeric nanomaterials for islet targeting and immunotherapeutic delivery. Nano Letters. 12: 203-8. PMID 22196766 DOI: 10.1021/Nl203334C  0.245
2018 Ha KQ, Zheng X, Kessinger C, Jaffer F, McCarthy J. Abstract 049: Novel Tirofiban Conjugate for the in vivo Detection of Activated Platelets Arteriosclerosis, Thrombosis, and Vascular Biology. 38. DOI: 10.1161/Atvb.38.Suppl_1.049  0.242
2015 Konishi M, Erdem SS, Weissleder R, Lichtman AH, McCarthy J, Libby P. Imaging Granzyme B Activity Assesses Immune-Mediated Myocarditis. Circulation Research. PMID 26199323 DOI: 10.1161/Circresaha.115.306364  0.241
2020 Bose RJ, Tharmalingam N, Garcia Marques FJ, Sukumar UK, Natarajan A, Zeng Y, Robinson E, Bermudez A, Chang E, Habte F, Pitteri SJ, McCarthy J, Gambhir SS, Massoud TF, Mylonakis E, et al. Reconstructed Apoptotic Bodies as Targeted 'Nano Decoys' to Treat Intracellular Bacterial Infections within Macrophages and Cancer Cells. Acs Nano. PMID 32347709 DOI: 10.1021/Acsnano.0C00921  0.237
2010 McCarthy JR. Multifunctional agents for concurrent imaging and therapy in cardiovascular disease. Advanced Drug Delivery Reviews. 62: 1023-30. PMID 20654664 DOI: 10.1016/J.Addr.2010.07.004  0.237
2019 Nurunnabi, Khatun Z, Badruddoza AZM, McCarthy JR, Lee Y, Huh KM. Biomaterials and Bioengineering Approaches for Mitochondria and Nuclear Targeting Drug Delivery Acs Biomaterials Science & Engineering. 5: 1645-1660. DOI: 10.1021/Acsbiomaterials.8B01615  0.236
2006 Choi Y, McCarthy JR, Weissleder R, Tung CH. Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapy. Chemmedchem. 1: 458-63. PMID 16892381 DOI: 10.1002/Cmdc.200500036  0.235
2015 Hara T, Ughi GJ, McCarthy JR, Erdem SS, Mauskapf A, Lyon SC, Fard AM, Edelman ER, Tearney GJ, Jaffer FA. Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo. European Heart Journal. PMID 26685129 DOI: 10.1093/Eurheartj/Ehv677  0.234
2007 Kelly KA, Carson J, McCarthy JR, Weissleder R. Novel peptide sequence ("IQ-tag") with high affinity for NIR fluorochromes allows protein and cell specific labeling for in vivo imaging. Plos One. 2: e665. PMID 17653285 DOI: 10.1371/Journal.Pone.0000665  0.232
2013 McCarthy JR. Book Review: The Handbook of Nanomedicine (2nd Edition) Nanomedicine. 8: 173-175. DOI: 10.2217/Nnm.12.207  0.23
2006 McCarthy JR, Jaffer FA, Weissleder R. A macrophage-targeted theranostic nanoparticle for biomedical applications. Small (Weinheim An Der Bergstrasse, Germany). 2: 983-7. PMID 17193154 DOI: 10.1002/Smll.200600139  0.223
2020 Cui J, Kessinger CW, Jhajj HS, Grau MS, Misra S, Libby P, McCarthy JR, Jaffer FA. Atorvastatin Reduces Fibrin Deposition and Macrophage Accumulation, and Improves Primary Patency Duration and Maturation of Murine Arteriovenous Fistula. Journal of the American Society of Nephrology : Jasn. PMID 32152232 DOI: 10.1681/Asn.2019060612  0.223
2012 McCarthy JR, Sazonova IY, Erdem SS, Hara T, Thompson BD, Patel P, Botnaru I, Lin CP, Reed GL, Weissleder R, Jaffer FA. Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy. Nanomedicine (London, England). 7: 1017-28. PMID 22348271 DOI: 10.2217/Nnm.11.179  0.219
2020 Jing JLJ, Pei Yi T, Bose RJC, McCarthy JR, Tharmalingam N, Madheswaran T. Hand Sanitizers: A Review on Formulation Aspects, Adverse Effects, and Regulations. International Journal of Environmental Research and Public Health. 17. PMID 32403261 DOI: 10.3390/Ijerph17093326  0.217
2013 Saxena A, Kessinger CW, Thompson B, McCarthy JR, Iwamoto Y, Lin CP, Jaffer FA. High-resolution optical mapping of inflammatory macrophages following endovascular arterial injury. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 282-9. PMID 23090852 DOI: 10.1007/S11307-012-0599-2  0.212
2014 Lauriol J, Keith K, Jaffré F, Couvillon A, Saci A, Goonasekera SA, McCarthy JR, Kessinger CW, Wang J, Ke Q, Kang PM, Molkentin JD, Carpenter C, Kontaridis MI. RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis. Science Signaling. 7: ra100. PMID 25336613 DOI: 10.1126/Scisignal.2005262  0.2
2019 Kaikkonen LA, Sätzler V, Roy A, Contreras M, Xu B, Stroll S, McCarthy J, Molkentin JD, Das S, Kontaridis M. Abstract 252: Activated Fibroblast-specific Deletion of RhoA Reduces Cardiac Fibrosis Through Regulation of the Non-canonical p38-MAPK Signaling Pathway Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.252  0.198
2020 Bose RJC, McCarthy JR. Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19. Drug Discovery Today. PMID 32592868 DOI: 10.1016/J.Drudis.2020.06.021  0.198
2018 Baker CE, Moore-Lotridge SN, Hysong AA, Posey SL, Robinette JP, Blum DM, Benvenuti MA, Cole HA, Egawa S, Okawa A, Saito M, McCarthy JR, Nyman JS, Yuasa M, Schoenecker JG. Bone Fracture Acute Phase Response-A Unifying Theory of Fracture Repair: Clinical and Scientific Implications. Clinical Reviews in Bone and Mineral Metabolism. 16: 142-158. PMID 30930699 DOI: 10.1007/S12018-018-9256-X  0.197
2009 McCarthy JR. The future of theranostic nanoagents. Nanomedicine (London, England). 4: 693-5. PMID 19839803 DOI: 10.2217/Nnm.09.58  0.197
1977 McCarthy JR, Moore JL, Wysong DV. 3-N-Substituted aminomethyl derivatives of rifamycin SV. A convenient method of synthesis, cyclization of certain derivatives, and anticellular and antiviral activities of several derivatives. Journal of Medicinal Chemistry. 20: 1272-6. PMID 198544  0.183
2006 Rojo I, Martín JA, Broughton H, Timm D, Erickson J, Yang HC, McCarthy JR. Macrocyclic peptidomimetic inhibitors of beta-secretase (BACE): first X-ray structure of a macrocyclic peptidomimetic-BACE complex. Bioorganic & Medicinal Chemistry Letters. 16: 191-5. PMID 16249081 DOI: 10.1016/j.bmcl.2005.09.003  0.18
2003 Godfrey AG, Brooks DA, Hay LA, Peters M, McCarthy JR, Mitchell D. Application of the Dakin-West reaction for the synthesis of oxazole-containing dual PPARalpha/gamma agonists. The Journal of Organic Chemistry. 68: 2623-32. PMID 12662031 DOI: 10.1021/jo026655v  0.169
1966 McCarthy JR, Robins MJ, Townsend LB, Robins RK. Purine nucleosides. XIV. Unsaturated furanosyl adenine nucleosides prepared via base-catalyzed elimination reactions of 2'-deoxyadenosine derivatives. Journal of the American Chemical Society. 88: 1549-53. PMID 5914527 DOI: 10.1021/Ja00959A043  0.168
1991 Jarvi ET, McCarthy JR, Mehdi S, Matthews DP, Edwards ML, Prakash NJ, Bowlin TL, Sunkara PS, Bey P. 4',5'-unsaturated 5'-halogenated nucleosides. Mechanism-based and competitive inhibitors of S-adenosyl-L-homocysteine hydrolase. Journal of Medicinal Chemistry. 34: 647-56. PMID 1995889  0.165
2003 Zhu YF, Wilcoxen K, Gross T, Connors P, Strack N, Gross R, Huang CQ, McCarthy JR, Xie Q, Ling N, Chen C. 6,7-dihydroxyisoquinoline-3-carboxylic acids are potent inhibitors on the binding of insulin-like growth factor (IGF) to IGF-binding proteins: optimization of the 1-position benzoyl side chain. Bioorganic & Medicinal Chemistry Letters. 13: 1927-30. PMID 12749900 DOI: 10.1016/S0960-894X(03)00321-4  0.162
1966 Robins MJ, McCarthy JR, Robins RK. Purine nucleosides. XII. The preparation of 2',3'-dideoxyadenosine, 2',5'-dideoxyadenosine, and 2',3',5'-trideoxyadenosine from 2'-deoxyadenosine. Biochemistry. 5: 224-31. PMID 5938940 DOI: 10.1021/Bi00865A029  0.152
2003 Hu J, Cwi CL, Smiley DL, Timm D, Erickson JA, McGee JE, Yang HC, Mendel D, May PC, Shapiro M, McCarthy JR. Design and synthesis of statine-containing BACE inhibitors. Bioorganic & Medicinal Chemistry Letters. 13: 4335-9. PMID 14643321 DOI: 10.1016/J.Bmcl.2003.09.037  0.151
2021 Ha K, Zheng X, Kessinger CW, Mauskapf A, Li W, Kawamura Y, Orii M, Hilderbrand SA, Jaffer FA, McCarthy JR. Platelet Detection Using a Glycoprotein IIb/IIIa-Targeted Near-Infrared Fluorescence Imaging Probe. Acs Sensors. PMID 34056903 DOI: 10.1021/acssensors.1c00124  0.146
2005 Lowe RF, Nelson J, Dang TN, Crowe PD, Pahuja A, McCarthy JR, Grigoriadis DE, Conlon P, Saunders J, Chen C, Szabo T, Chen TK, Bozigian H. Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists. Journal of Medicinal Chemistry. 48: 1540-9. PMID 15743196 DOI: 10.1021/jm049339c  0.142
2003 Wilcoxen K, Huang CQ, McCarthy JR, Grigoriadis DE, Chen C. Synthesis of 3-phenylpyrazolo[4,3-b]pyridines via a convenient synthesis of 4-amino-3-arylpyrazoles and SAR of corticotropin-releasing factor receptor type-1 antagonists. Bioorganic & Medicinal Chemistry Letters. 13: 3367-70. PMID 12951127 DOI: 10.1016/S0960-894X(03)00621-8  0.136
2003 Huang CQ, Wilcoxen K, McCarthy JR, Haddach M, Grigoriadis D, Chen C. Synthesis of 1-methyl-3-phenylpyrazolo[4,3-b]pyridines via a methylation of 4-phthalimino-3-phenylpyrazoles and optimization toward highly potent corticotropin-releasing factor type-1 antagonists. Bioorganic & Medicinal Chemistry Letters. 13: 3371-4. PMID 12951128 DOI: 10.1016/S0960-894X(03)00622-X  0.134
2001 Brooks DA, Etgen GJ, Rito CJ, Shuker AJ, Dominianni SJ, Warshawsky AM, Ardecky R, Paterniti JR, Tyhonas J, Karanewsky DS, Kauffman RF, Broderick CL, Oldham BA, Montrose-Rafizadeh C, Winneroski LL, ... ... McCarthy JR, et al. Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists. Journal of Medicinal Chemistry. 44: 2061-4. PMID 11405642 DOI: 10.1021/jm0155188  0.126
2009 Bender DM, Bao J, Dantzig AH, Diseroad WD, Law KL, Magnus NA, Peterson JA, Perkins EJ, Pu YJ, Reutzel-Edens SM, Remick DM, Starling JJ, Stephenson GA, Vaid RK, Zhang D, ... McCarthy JR, et al. Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine. Journal of Medicinal Chemistry. 52: 6958-61. PMID 19860433 DOI: 10.1021/jm901181h  0.126
2008 Bender DM, Peterson JA, McCarthy JR, Gunaydin H, Takano Y, Houk KN. Cyclopropanecarboxylic acid esters as potential prodrugs with enhanced hydrolytic stability. Organic Letters. 10: 509-11. PMID 18181639 DOI: 10.1021/Ol702892E  0.124
2003 Huang CQ, Wilcoxen K, McCarthy JR, Haddach M, Webb TR, Gu J, Xie YF, Grigoriadis DE, Chen C. Synthesis and SAR of 8-arylquinolines as potent corticotropin-releasing factor1 (CRF1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13: 3375-9. PMID 12951129 DOI: 10.1016/S0960-894X(03)00684-X  0.123
1998 Miller SC, McCarthy JR, Sabol JS. Terminal fluoroolefins. The synthesis of novel carboacyclic nucleosides. Nucleosides & Nucleotides. 17: 1099-113. PMID 9708325 DOI: 10.1080/07328319808004223  0.123
1968 McCarthy JR, Robins RK, Robins MJ. Purine nucleosides. XXII. The synthesis of angustmycin A (decoyinine) and related unsaturated nucleosides. Journal of the American Chemical Society. 90: 4993-9. PMID 5665542 DOI: 10.1021/Ja01020A038  0.122
2004 Chen C, Wilcoxen KM, Huang CQ, McCarthy JR, Chen T, Grigoriadis DE. Optimization of 3-phenylpyrazolo[1,5-a]pyrimidines as potent corticotropin-releasing factor-1 antagonists with adequate lipophilicity and water solubility. Bioorganic & Medicinal Chemistry Letters. 14: 3669-73. PMID 15203140 DOI: 10.1016/J.Bmcl.2004.05.019  0.12
1985 McCarthy JR, Wright DL, Schuster AJ, Abdallah AH, Shea PJ, Eyster R. New bicyclic antidepressant agent. Synthesis and activity of napactadine and related compounds. Journal of Medicinal Chemistry. 28: 1721-7. PMID 4067998 DOI: 10.1021/JM00149A031  0.12
1990 Matthews DP, McCarthy JR, Whitten JP, Kastner PR, Barney CL, Marshall FN, Ertel MA, Burkhard T, Shea PJ, Kariya T. Synthesis and cardiotonic activity of novel biimidazoles. Journal of Medicinal Chemistry. 33: 317-27. PMID 2153209  0.115
1986 McCarthy JR, McCowan J, Zimmerman MB, Wenger MA, Emmert LW. Synthesis and renal vasodilator activity of 2-chlorodopamine and N-substituted derivatives. Journal of Medicinal Chemistry. 29: 1586-90. PMID 3528490  0.114
2004 Webb TR, Moran T, Huang CQ, McCarthy JR, Grigoriadis DE, Chen C. Synthesis of benzoylpyrimidines as antagonists of the corticotropin-releasing factor-1 receptor. Bioorganic & Medicinal Chemistry Letters. 14: 3869-73. PMID 15225687 DOI: 10.1016/J.Bmcl.2004.05.072  0.114
2001 Chen C, Dagnino R, Huang CQ, McCarthy JR, Grigoriadis DE. 1-Alkyl-3-amino-5-aryl-1H-[1,2,4]triazoles: novel synthesis via cyclization of N-acyl-S-methylisothioureas with alkylhydrazines and their potent corticotropin-releasing factor-1 (CRF(1)) receptor antagonist activities. Bioorganic & Medicinal Chemistry Letters. 11: 3165-8. PMID 11720866  0.113
1999 Chen C, Wilcoxen K, Zhu YF, Kim Ki, McCarthy JR. Coupling of 2-Substituted 1-Fluorovinylstannanes with Organic Halides Catalyzed by Palladium(0)/Copper(I) Iodide. A Mild and Stereospecific Method to Monofluoroolefins. The Journal of Organic Chemistry. 64: 3476-3482. PMID 11674468 DOI: 10.1021/JO982200N  0.111
2015 McCarthy JR. A convenient synthesis of the antibacterial agent linezolid Tetrahedron Letters. 56: 6846-6847. DOI: 10.1016/j.tetlet.2015.10.082  0.107
2023 Knipe RS, Nurunnabi M, Probst CK, Spinney JJ, Abe E, Bose RJC, Ha K, Logue A, Nguyen T, Servis R, Drummond M, Haring A, Brazee PL, Medoff BD, McCarthy JR. Myofibroblast-Specific Inhibition of the Rho Kinase-MRTF-SRF Pathway Using Nanotechnology for the Prevention of Pulmonary Fibrosis. American Journal of Physiology. Lung Cellular and Molecular Physiology. PMID 36625494 DOI: 10.1152/ajplung.00086.2022  0.107
1992 Prakash NJ, Davis GF, Jarvi ET, Edwards ML, McCarthy JR, Bowlin TL. Antiretroviral activity of mechanism-based irreversible inhibitors of S-adenosylhomocysteine hydrolase. Life Sciences. 50: 1425-35. PMID 1374145 DOI: 10.1016/0024-3205(92)90261-M  0.105
2021 Bose RJC, Ha K, McCarthy JR. Bio-inspired nanomaterials as novel options for the treatment of cardiovascular disease. Drug Discovery Today. PMID 33561512 DOI: 10.1016/j.drudis.2021.01.035  0.104
1967 Bloch A, Robins MJ, McCarthy JR. The role of the 5'-hydroxyl group of adenosine in determining substrate specificity for adenosine deaminase. Journal of Medicinal Chemistry. 10: 908-12. PMID 6048501 DOI: 10.1021/Jm00317A034  0.099
1990 McCarthy JR, Matthews DP, Broersma RJ, McDermott RD, Kastner PR, Hornsperger JM, Demeter DA, Weintraub HJ, Whitten JP. 1-(Thienylalkyl)imidazole-2(3H)-thiones as potent competitive inhibitors of dopamine beta-hydroxylase. Journal of Medicinal Chemistry. 33: 1866-73. PMID 2362264 DOI: 10.1021/jm00169a006  0.097
2004 Wang M, Winneroski LL, Ardecky RJ, Babine RE, Brooks DA, Etgen GJ, Hutchison DR, Kauffman RF, Kunkel A, Mais DE, Montrose-Rafizadeh C, Ogilvie KM, Oldham BA, Peters MK, Rito CJ, ... ... McCarthy JR, et al. Conversion of human-selective PPARalpha agonists to human/mouse dual agonists: a molecular modeling analysis. Bioorganic & Medicinal Chemistry Letters. 14: 6113-6. PMID 15546740 DOI: 10.1016/j.bmcl.2004.09.031  0.097
2004 Chen C, Wilcoxen KM, Huang CQ, Xie YF, McCarthy JR, Webb TR, Zhu YF, Saunders J, Liu XJ, Chen TK, Bozigian H, Grigoriadis DE. Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists. Journal of Medicinal Chemistry. 47: 4787-98. PMID 15341493 DOI: 10.1021/Jm040058E  0.096
2015 Hara T, Ughi GJ, McCarthy JR, Erdem SS, Mauskapf A, Lyon SC, Fard AM, Edelman ER, Tearney GJ, Jaffer FA. Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo. European Heart Journal. PMID 28164216 DOI: 10.1093/eurheartj/ehv677  0.095
1996 van der Donk WA, Yu G, Silva DJ, Stubbe J, McCarthy JR, Jarvi ET, Matthews DP, Resvick RJ, Wagner E. Inactivation of ribonucleotide reductase by (E)-2'-fluoromethylene-2'-deoxycytidine 5'-diphosphate: a paradigm for nucleotide mechanism-based inhibitors. Biochemistry. 35: 8381-91. PMID 8679596 DOI: 10.1021/Bi960190J  0.093
2003 Zhu YF, Wang XC, Connors P, Wilcoxen K, Gao Y, Gross R, Strack N, Gross T, McCarthy JR, Xie Q, Ling N, Chen C. Quinoline-carboxylic acids are potent inhibitors that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins. Bioorganic & Medicinal Chemistry Letters. 13: 1931-4. PMID 12749901 DOI: 10.1016/S0960-894X(03)00322-6  0.093
2022 Chislett M, Hurtubise K, McCarthy J, Hoyles C. The implementation of a precision case management model in a Canadian inpatient rehabilitation center: The 12-months post-implementation findings of a quality improvement project. Health Services Management Research. 9514848221109832. PMID 35723217 DOI: 10.1177/09514848221109832  0.091
2020 Bose RJC, Tharmalingam N, Choi Y, Madheswaran T, Paulmurugan R, McCarthy JR, Lee SH, Park H. Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery. International Journal of Nanomedicine. 15: 8437-8449. PMID 33162754 DOI: 10.2147/IJN.S271850  0.091
2021 Bose RJ, Kumar US, Garcia-Marques F, Zeng Y, Habte F, McCarthy JR, Pitteri S, Massoud TF, Paulmurugan R. Engineered Cell-Derived Vesicles Displaying Targeting Peptide and Functionalized with Nanocarriers for Therapeutic microRNA Delivery to Triple-Negative Breast Cancer in Mice. Advanced Healthcare Materials. e2101387. PMID 34879180 DOI: 10.1002/adhm.202101387  0.091
2020 Loo YS, Bose RJC, McCarthy JR, Mat Azmi ID, Madheswaran T. Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications. Drug Discovery Today. PMID 33383213 DOI: 10.1016/j.drudis.2020.12.017  0.089
2023 Bose RJ, Kessinger CW, Dhammu T, Singh T, Shealy MW, Ha K, Collandra R, Himbert S, Garcia FJ, Oleinik N, Xu B, Kontaridis MI, Rheinstädter MC, Ogretmen B, Menick DR, ... McCarthy JR, et al. Biomimetic Nanomaterials for The Immunomodulation of The Cardiosplenic Axis Post-Myocardial Infarction. Advanced Materials (Deerfield Beach, Fla.). e2304615. PMID 37934471 DOI: 10.1002/adma.202304615  0.088
1993 Van Sickle WA, Wilson PK, Wannamaker MW, Cooper JR, Flanagan MA, McCarthy JR, Bey P, Jackson RL. An alternative mechanism for the inhibition of cholesterol biosynthesis in HepG2 cells by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol (MDL 28,815). The Journal of Pharmacology and Experimental Therapeutics. 267: 1243-9. PMID 8263786  0.087
2009 Green JE, Bender DM, Jackson S, O'Donnell MJ, McCarthy JR. Mitsunobu approach to the synthesis of optically active alpha,alpha-disubstituted amino acids. Organic Letters. 11: 807-10. PMID 19159255 DOI: 10.1021/ol802325h  0.086
2005 Dyck B, Grigoriadis DE, Gross RS, Guo Z, Haddach M, Marinkovic D, McCarthy JR, Moorjani M, Regan CF, Saunders J, Schwaebe MK, Szabo T, Williams JP, Zhang X, Bozigian H, et al. Potent, orally active corticotropin-releasing factor receptor-1 antagonists containing a tricyclic pyrrolopyridine or pyrazolopyridine core. Journal of Medicinal Chemistry. 48: 4100-10. PMID 15943483 DOI: 10.1021/Jm050070M  0.084
2004 Huang CQ, Wilcoxen KM, Grigoriadis DE, McCarthy JR, Chen C. Design and synthesis of 3-(2-pyridyl)pyrazolo[1,5-a]pyrimidines as potent CRF1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14: 3943-7. PMID 15225703 DOI: 10.1016/J.Bmcl.2004.05.056  0.083
1992 Wannamaker MW, Waid PP, Van Sickle WA, McCarthy JR, Wilson PK, Schatzman GL, Moore WR. N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclase. Journal of Medicinal Chemistry. 35: 3581-3. PMID 1404239  0.082
2005 Guo Z, Tellew JE, Gross RS, Dyck B, Grey J, Haddach M, Kiankarimi M, Lanier M, Li BF, Luo Z, McCarthy JR, Moorjani M, Saunders J, Sullivan R, Zhang X, et al. Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonists. Journal of Medicinal Chemistry. 48: 5104-7. PMID 16078829 DOI: 10.1021/JM050384+  0.082
2004 Xu Y, Rito CJ, Etgen GJ, Ardecky RJ, Bean JS, Bensch WR, Bosley JR, Broderick CL, Brooks DA, Dominianni SJ, Hahn PJ, Liu S, Mais DE, Montrose-Rafizadeh C, Ogilvie KM, ... ... McCarthy JR, et al. Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists. Journal of Medicinal Chemistry. 47: 2422-5. PMID 15115385 DOI: 10.1021/jm0342616  0.081
2008 Zhang D, Bender DM, Victor F, Peterson JA, Boyer RD, Stephenson GA, Azman A, McCarthy JR. Facile rearrangement of N4-(α-aminoacyl)cytidines to N-(4-cytidinyl)amino acid amides Tetrahedron Letters. 49: 2052-2055. DOI: 10.1016/j.tetlet.2008.02.015  0.08
2004 Yang HC, Chai X, Mosior M, Kohn W, Boggs LN, Erickson JA, McClure DB, Yeh WK, Zhang L, Gonzalez-DeWhitt P, Mayer JP, Martin JA, Hu J, Chen SH, Bueno AB, ... ... McCarthy JR, et al. Biochemical and kinetic characterization of BACE1: investigation into the putative species-specificity for beta- and beta'-cleavage sites by human and murine BACE1. Journal of Neurochemistry. 91: 1249-59. PMID 15584902 DOI: 10.1111/j.1471-4159.2004.02764.x  0.079
2017 Kelly LP, Devasahayam AJ, Chaves AR, Wallack EM, McCarthy J, Basset FA, Ploughman M. Intensifying Functional Task Practice to Meet Aerobic Training Guidelines in Stroke Survivors. Frontiers in Physiology. 8: 809. PMID 29123485 DOI: 10.3389/fphys.2017.00809  0.078
1986 Bargar TM, Broersma RJ, Creemer LC, McCarthy JR, Hornsperger JM, Palfreyman MG, Wagner J, Jung MJ. Unsaturated heterocyclic amines as potent time-dependent inhibitors of dopamine beta-hydroxylase. Journal of Medicinal Chemistry. 29: 315-7. PMID 3950911  0.077
2011 Mccarthy JR, Weissleder R. Multimodal Imaging and Therapy with Magnetofluorescent Nanoparticles Nanoplatform-Based Molecular Imaging. 593-613. DOI: 10.1002/9780470767047.ch24  0.075
1985 McCarthy JR, Zimmerman MB, Trepanier DL, LeTourneau ME, Wiedeman PE, Whitten JP, Broersma RJ, Shea PJ, Wiech NL, Huffman JC. 6,7-Dihydro-5-[[(cis-2-hydroxy-trans-3-phenoxycyclopentyl)amino] methyl]-2-methylbenzo[b]thiophen-4(5H)-one: a novel alpha 1-adrenergic receptor antagonist and renal vasodilator. Journal of Medicinal Chemistry. 28: 1142-5. PMID 2863377  0.075
1990 Bitonti AJ, Baumann RJ, Jarvi ET, McCarthy JR, McCann PP. Antimalarial activity of a 4',5'-unsaturated 5'-fluoroadenosine mechanism-based inhibitor of S-adenosyl-L-homocysteine hydrolase. Biochemical Pharmacology. 40: 601-6. PMID 2200410  0.066
1983 Oatis JE, Baker JP, McCarthy JR, Knapp DR. Synthesis and chromatographic separation of the glucuronides of (R)- and (S)-propranolol. Journal of Medicinal Chemistry. 26: 1687-91. PMID 6644737  0.065
2005 Vidal P, Timm D, Broughton H, Chen SH, Martín JA, Rivera-Sagredo A, McCarthy JR, Shapiro MJ, Espinosa JF. Preorganization of the hydroxyethylene dipeptide isostere: the preferred conformation in solution resembles the conformation bound to BACE. Journal of Medicinal Chemistry. 48: 7623-7. PMID 16302802 DOI: 10.1021/jm050631+  0.065
1996 Whitten JP, Xie YF, Erickson PE, Webb TR, De Souza EB, Grigoriadis DE, McCarthy JR. Rapid microscale synthesis, a new method for lead optimization using robotics and solution phase chemistry: application to the synthesis and optimization of corticotropin-releasing factor1 receptor antagonists. Journal of Medicinal Chemistry. 39: 4354-7. PMID 8893828 DOI: 10.1021/Jm960148M  0.064
1990 Mehdi S, Jarvi ET, Koehl JR, McCarthy JR, Bey P. The mechanism of inhibition of S-adenosyl-L-homocysteine hydrolase by fluorine-containing adenosine analogs. Journal of Enzyme Inhibition. 4: 1-13. PMID 2094766  0.063
2020 Unudurthi SD, Luthra P, Bose RJC, McCarthy J, Kontaridis MI. Cardiac inflammation in COVID-19: Lessons from heart failure. Life Sciences. 118482. PMID 32971105 DOI: 10.1016/j.lfs.2020.118482  0.061
1996 Chen C, Dagnino R, De Souza EB, Grigoriadis DE, Huang CQ, Kim KI, Liu Z, Moran T, Webb TR, Whitten JP, Xie YF, McCarthy JR. Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists. Journal of Medicinal Chemistry. 39: 4358-60. PMID 8893829 DOI: 10.1021/Jm960149E  0.06
2016 McCarthy J. Myalgias and Myopathies: Fibromyalgia. Fp Essentials. 440: 11-5. PMID 26734831  0.058
2004 Huang CQ, Grigoriadis DE, Liu Z, McCarthy JR, Ramphal J, Webb T, Whitten JP, Xie MY, Chen C. Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor(1) (CRF(1)) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14: 2083-6. PMID 15080983 DOI: 10.1016/j.bmcl.2004.02.053  0.057
2021 Kelly LP, Devasahayam AJ, Chaves AR, Curtis ME, Randell EW, McCarthy J, Basset FA, Ploughman M. Task-Oriented Circuit Training as an Alternative to Ergometer-Type Aerobic Exercise Training after Stroke. Journal of Clinical Medicine. 10. PMID 34070731 DOI: 10.3390/jcm10112423  0.054
2021 McCarthy J, Castro P, Cottier R, Buttell J, Arshad Q, Kheradmand A, Kaski D. Multisensory contribution in visuospatial orientation: an interaction between neck and trunk proprioception. Experimental Brain Research. PMID 34120203 DOI: 10.1007/s00221-021-06146-0  0.053
1999 McCarthy JR, Heinrichs SC, Grigoriadis DE. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Current Pharmaceutical Design. 5: 289-315. PMID 10213797  0.053
2002 Etgen GJ, Oldham BA, Johnson WT, Broderick CL, Montrose CR, Brozinick JT, Misener EA, Bean JS, Bensch WR, Brooks DA, Shuker AJ, Rito CJ, McCarthy JR, Ardecky RJ, Tyhonas JS, et al. A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models. Diabetes. 51: 1083-7. PMID 11916929  0.052
1994 Bitonti AJ, Dumont JA, Bush TL, Cashman EA, Cross-Doersen DE, Wright PS, Matthews DP, McCarthy JR, Kaplan DA. Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase. Cancer Research. 54: 1485-90. PMID 8137252  0.05
2018 Barrett M, Snow JC, Kirkland MC, Kelly LP, Gehue M, Downer MB, McCarthy J, Ploughman M. Excessive sedentary time during in-patient stroke rehabilitation. Topics in Stroke Rehabilitation. 1-9. PMID 29609499 DOI: 10.1080/10749357.2018.1458461  0.046
1993 Wolos JA, Frondorf KA, Davis GF, Jarvi ET, McCarthy JR, Bowlin TL. Selective inhibition of T cell activation by an inhibitor of S-adenosyl-L-homocysteine hydrolase. Journal of Immunology (Baltimore, Md. : 1950). 150: 3264-73. PMID 8468468  0.043
2005 Wyatt F, Godoy S, Autrey L, McCarthy J, Heimdal J. Using a logarithmic regression to identify the heart-rate threshold in cyclists. Journal of Strength and Conditioning Research / National Strength & Conditioning Association. 19: 838-41. PMID 16287375 DOI: 10.1519/R-16084.1  0.042
2007 Siegler JC, Robergs RA, Faria EW, Wyatt FB, McCarthy J. Noninvasive profiling of exercise-induced hypoxemia in competitive cyclists Research in Sports Medicine. 15: 61-66. PMID 17365952 DOI: 10.1080/15438620601184364  0.042
2012 Edwards R, McCarthy JR, Gillies V. The politics of concepts: family and its (putative) replacements. The British Journal of Sociology. 63: 730-46. PMID 23240840 DOI: 10.1111/j.1468-4446.2012.01434.x  0.04
2008 Ploughman M, McCarthy J, Bossé M, Sullivan HJ, Corbett D. Does treadmill exercise improve performance of cognitive or upper-extremity tasks in people with chronic stroke? A randomized cross-over trial. Archives of Physical Medicine and Rehabilitation. 89: 2041-7. PMID 18996231 DOI: 10.1016/J.Apmr.2008.05.017  0.039
1995 Bridges CG, Ahmed SP, Sunkara PS, McCarthy JR, Tyms AS. The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infection. Antiviral Research. 27: 325-34. PMID 8540753  0.038
2018 Abraha B, Chaves AR, Kelly LP, Wallack EM, Wadden KP, McCarthy J, Ploughman M. A Bout of High Intensity Interval Training Lengthened Nerve Conduction Latency to the Non-exercised Affected Limb in Chronic Stroke. Frontiers in Physiology. 9: 827. PMID 30013489 DOI: 10.3389/fphys.2018.00827  0.038
2019 King M, Kelly LP, Wallack EM, Hasan SMM, Kirkland MC, Curtis ME, Chatterjee T, McCarthy J, Ploughman M. Serum levels of insulin-like growth factor-1 and brain-derived neurotrophic factor as potential recovery biomarkers in stroke. Neurological Research. 1-10. PMID 30620251 DOI: 10.1080/01616412.2018.1564451  0.036
2016 McCarthy J, Davis A. Diagnosis and Management of Vertebral Compression Fractures. American Family Physician. 94: 44-50. PMID 27386723  0.034
2011 McCarthy JR, Edwards R. Key concepts in family studies Key Concepts in Family Studies. 1-247. DOI: 10.4135/9781446250990  0.032
2020 Devasahayam AJ, Chaves AR, Lasisi WO, Curtis ME, Wadden KP, Kelly LP, Pretty R, Chen A, Wallack EM, Newell CJ, Williams JB, Kenny H, Downer MB, McCarthy J, Moore CS, et al. Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study. Bmc Neurology. 20: 33. PMID 31969132 DOI: 10.1186/S12883-020-1611-0  0.032
2002 Zorrilla EP, Schulteis G, Ormsby A, Klaassen A, Ling N, McCarthy JR, Koob GF, De Souza EB. Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors. Brain Research. 952: 200-10. PMID 12376180 DOI: 10.1016/S0006-8993(02)03345-0  0.031
2014 Ploughman M, Shears J, Harris C, Hogan SH, Drodge O, Squires S, McCarthy J. Effectiveness of a novel community exercise transition program for people with moderate to severe neurological disabilities. Neurorehabilitation. 35: 105-12. PMID 24990000 DOI: 10.3233/NRE-141090  0.028
2021 Kelly LP, Basset FA, McCarthy J, Ploughman M. Normobaric Hypoxia Exposure During Treadmill Aerobic Exercise After Stroke: A Safety and Feasibility Study. Frontiers in Physiology. 12: 702439. PMID 34483958 DOI: 10.3389/fphys.2021.702439  0.026
1997 Johnson RG, Cohn WE, Thurer RL, McCarthy JR, Sirois CA, Weintraub RM. Cutaneous closure after cardiac operations: a controlled, randomized, prospective comparison of intradermal versus staple closures. Annals of Surgery. 226: 606-12. PMID 9389394  0.026
2019 Ploughman M, Eskes GA, Kelly LP, Kirkland MC, Devasahayam AJ, Wallack EM, Abraha B, Hasan SMM, Downer MB, Keeler L, Wilson G, Skene E, Sharma I, Chaves AR, Curtis ME, ... ... McCarthy J, et al. Synergistic Benefits of Combined Aerobic and Cognitive Training on Fluid Intelligence and the Role of IGF-1 in Chronic Stroke. Neurorehabilitation and Neural Repair. 1545968319832605. PMID 30816066 DOI: 10.1177/1545968319832605  0.023
2001 Fedalen PA, Bard MR, Piacentino V, Fisher CA, McCarthy JR, Schina MJ, Furukawa S, Garcia JP. Intraluminal shunt placement and off-pump coronary revascularization for coronary artery stab wound. The Journal of Trauma. 50: 133-5. PMID 11231684 DOI: 10.1097/00005373-200101000-00027  0.021
2012 Weller S, Zontini E, McCarthy JR. Part IV summary: Caring across the life course Critical Approaches to Care: Understanding Caring Relations, Identities and Cultures. 157-159. DOI: 10.4324/9780203112083  0.02
1987 Carton EG, McDonald N, McCarthy JR. Intrathecal morphine in labour--efficacy and side effects. Irish Journal of Medical Science. 156: 323-7. PMID 3692728 DOI: 10.1007/BF02951264  0.019
2020 Chislett M, Ploughman M, McCarthy J. Factors Associated With Prolonged Length of Stay and Failed Lower Limb Prosthetic Fitting During Inpatient Rehabilitation. Archives of Rehabilitation Research and Clinical Translation. 2: 100084. PMID 33543107 DOI: 10.1016/j.arrct.2020.100084  0.017
1987 Gordon WP, McCarthy JR, Chang SY. Metabolism of 2-(2-thienyl)allylamine hydrochloride in the rat: identification of a novel metabolite. Biochemical and Biophysical Research Communications. 145: 575-80. PMID 3593353  0.015
2011 Yeh WK, Yang HC, McCarthy JR. Enzyme Technologies: Metagenomics, Evolution, Biocatalysis, and Biosynthesis Enzyme Technologies: Metagenomics, Evolution, Biocatalysis, and Biosynthesis. DOI: 10.1002/9780470627303  0.015
2014 McCarthy JR, Prokhovnik R. Embodied relationality and caring after death Body and Society. 20: 18-43. DOI: 10.1177/1357034X13506469  0.013
2007 McCarthy JR. 'They all look as if they're coping, but I'm not': The relational power/lessness of 'Youth' in responding to experiences of bereavement Journal of Youth Studies. 10: 285-303. DOI: 10.1080/13676260701262574  0.012
2012 McCarthy JR. The powerful relational language of 'family': Togetherness, belonging and personhood Sociological Review. 60: 68-90. DOI: 10.1111/j.1467-954X.2011.02045.x  0.01
1996 Rundell KW, McCarthy JR. Effect of kinematic variables on performance in women during a cross-country ski race. Medicine and Science in Sports and Exercise. 28: 1413-7. PMID 8933492  0.01
1996 Taylor A, Phelan D, McCarthy JR. Pain relief following cardiac surgery: a review. Irish Journal of Medical Science. 165: 1-9. PMID 8867486  0.01
1984 Blake S, Bonar F, MacDonald D, McCarthy JR, Flanagan M, Garrett J, Kirwan M. Pregnancy with constrictive pericarditis. Case reports. British Journal of Obstetrics and Gynaecology. 91: 404-6. PMID 6712902  0.01
1982 Friedman CD, McCarthy JR. Multiple primary malignant neoplasms. Imj. Illinois Medical Journal. 161: 115-6. PMID 6122671  0.01
1966 O'Driscoll K, McCarthy JR. Abruptio placentae and central venous pressures. The Journal of Obstetrics and Gynaecology of the British Commonwealth. 73: 923-9. PMID 5954185  0.01
Hide low-probability matches.